Role of differentiation in the pathogenesis and prevention of breast cancer

Endocrine-Related Cancer

Volumn 4, Issue 1, 1997, Pages 7-21

  Russo, J ^a   Russo, L H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DEVELOPMENT; BREAST DUCT; CANCER PREVENTION; CANCER RISK; CELL DIFFERENTIATION; GENETIC SUSCEPTIBILITY; GROWTH REGULATION; HORMONAL REGULATION; MENSTRUAL CYCLE; NONHUMAN; RAT; REVIEW;

EID: 0030993112     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0040007     Document Type: Review

References (84)

1. Alvarado MV, Russo J & Russo IH 1992 Immunolocalization of inhibin in the mammary gland of rats treated with hCG. Journal of Histochemistry and Cytochemistry 41 29-34.
2. Alvarado N, Ho T, Alvarado MV, Russo IH & Russo J 1992 Human chorionic gonadotropin (hCG) inhibits proliferation and induces the expression of inhibin in human breast epithelial cells (HBEC) in vitro. Proceedings of the American Association for Cancer Research 33 1672a.
3. Anderson TJ, Ferguson DJP & Raab GM 1982 Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. British Journal of Cancer 46 376-382.
4. Anderson TJ, Battersby S & King RJB 1989 Oral contraceptive use influences resting breast proliferation. Human Pathology 20 1139-1144.
5. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP, Koszalka M & Russo J 1991 Transformation of human breast epithelial cells by c-Ha-ras oncogene. Molecular Carcinogenesis 4 25-35.
6. Battersby S, Robertson BJ, Anderson TJ, King RJB & McPherson K 1992 Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. British Journal of Cancer 65 601-607.
7. Berenblum I 1976 A speculative review: the probable nature of promoting action, its significance in the understanding of the mechanism of carcinogenesis. Cancer Research 14 471-476.
8. Boring CC, Squires TS & Tang T 1993 Cancer statistics. CA Cancer Journal for Clinicians 43 72-76.
9. Calaf G & Russo J 1993 Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14 483-492.
10. Chan PC & Dao TL 1983 Effects of dietary fat on age-dependent sensitivity to mammary carcinogenesis. Cancer Letters 18 245-253.
11. Ciocca DR, Parente A & Russo J 1982 Endocrinological milieu and susceptibility of the rat mammary gland to carcinogenesis. American Journal of Pathology 109 47-56.
12. Daling JR, Malone KE, Voigt LF, White E & Weiss NS 1994 Risk of breast cancer among young women: relationship to abortion. Journal of the National Cancer Institute 88 1584-1602.
13. De Waard F & Trichopoulos D 1988 A unifying concept of the aetiology of breast cancer. International Journal of Cancer 41 666-669.
14. Ferguson DJP & Anderson TJ 1981 Morphologic evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. British Journal of Cancer 44 177-181.
15. Frei JV & Harsano T 1967 Increased susceptibility to low doses of carcinogen of epidermal cells in stimulated DNA synthesis. Cancer Research 27 1482-1491.
16. Gerdes J, Becker MHG, Key G & Kattoretti G 1992 Immunohistological detection of tumor growth fraction (ki-67 antigen) in formalin fixed and routinely processed tissues. Journal of Pathology 168 85-86.
17. Going JJ, Anderson TJ & Battersby S 1988 Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. American Journal of Pathology 130 193-204.
18. Henderson BE, Ross RK & Pike MC 1993 Hormonal chemoprevention of cancer in women. Science 259 633-638.
19. Huggins C & Yang NC 1962 Induction and extinction of mammary cancer. Science 137 25-28.
20. Huggins C, Grand LC & Brillantes FP 1959 Critical significance of breast structure in the induction of mammary cancer in the rat. Proceedings of the National Academy of Sciences of the USA 45 1294-1300.
21. John EM & Kelsey JL 1993 Radiation and other environmental exposures and breast cancer. Epidemiological Reviews 15 157-162.
22. Kakunaga T, Crow JD, Hamada H, Hirakawa T & Leavitt J 1983 Mechanisms of neoplastic transformation on human cells. In Human Carcinogenesis, p 371. Eds CC Harris & H Autrup. New York: Academic Press.
23. Laidlaw IJ, Clarke RB, Howell A, Owen AW, Potten CS & Anderson E 1995 The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136 167-171.
24. Longacre TA & Bartow SA 1986 A correlative morphologic study of human breast and endometrium in the menstrual cycle. American Journal of Surgical Pathology 10 382-393.
25. McGregor DH, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I & Beebe GW 1977 Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950-1989. Journal of the National Cancer Institute 59 799-811.
26. MacMahon B, Cole P, Liu M, Lowe CR, Mirra AP, Ravinihar B, Salber EJ, Valaoras VG & Yuasa S 1970 Age at first birth and breast cancer risk. Bulletin of the World Health Organization 34 209-221.
27. Marquardt H, Baker S, Tierney B, Grover PL & Sims P 1979 Comparison of mutagenesis and malignant transformation by dihydrodiols of 7,12-dimethylbenz(a)anthracene. British Journal of Cancer 39 540-547.
28. Masters JRW, Drife JO & Scarisbrick JJ 1977 Cyclic variations of DNA synthesis in human breast epithelium. Journal of the National Cancer Institute 58 1263-1265.
29. Matzuk MM, Finegold MJ, Su SGJ, Hsueh AJW & Bradley A 1992 α Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360 313-319.
30. Meyer JS 1987 Cell proliferation in normal human breast ducts, fibroadenomas, and other duct hyperplasias, measured by nuclear labeling with tritiated thymidine. Human Pathology 8 67-81.
31. Meyer JS & Connor RE 1982 Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labeling. Cancer 50 746-751.
32. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Gringberg ER & Willett WC 1996 Pregnancy termination in relation to risk of breast cancer. Journal of the American Medical Association 275 283-287.
33. Page DL & Anderson TJ 1987 Diagnostic Histopathology of the Breast. New York: Churchill Livingstone.
34. Parker SL, Tong T, Bolden S & Wingo PA 1996 Cancer statistics 1996. CA Cancer Journal for Clinicians 65 5-27.
35. Petersen OW, Hoyer PE & Van Deurs B 1987 Frequency and distribution of estrogen-receptor-positive cells in normal, nonlactating human breast. Cancer Research 47 5748-5751.
36. Potten CS, Watson RJ & Williams GT 1988 The effect of age and menstrual cycle upon proliferative activity of the normal human breast. British Journal of Cancer 58 163-170.
37. Ricketts L, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet JC, Nolan C & Coombes RC 1991 Estrogen and progesterone receptors in the normal female breast. Cancer Research 51 1817-1822.
38. Rogers AE & Lee SY 1986 Chemically-induced mammary gland tumors in rats: modulation by dietary fat. In Dietary Fat and Cancer, pp 255-268. Eds C Ip, DF Birt, AE Rogers & C Mettlin. New York: Alan R Liss.
39. Rosner B, Colditz G A & Willett WC 1994 Reproductive risk factors in a prospective study of breast cancer: The nurses health study. American Journal of Epidemiology 139 819-835.
40. Russo IH & Russo J 1978 Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz(a)anthracene. Journal of the National Cancer Institute 61 1439-1442.
41. Russo IH & Russo J 1988 Hormone prevention of mammary carcinogenesis: A new approach in anticancer research. AntiCancer Research 8 1247-1264.
42. Russo IH & Russo J 1989 Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol. Breast Cancer Research and Treatment 14 43-56.
43. Russo IH & Russo J 1993 Physiological basis of breast cancer prevention. European Journal of Cancer Prevention 2 101-111.
44. Russo IH & Russo J 1994 Role of hCG and inhibin in breast cancer (Review). International Journal of Oncology 4 297-306.
45. Russo IH, Gimotty P, Dupuis M & Russo J 1989 Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. British Journal of Cancer 59 210-216.
46. Russo IH, Koszalka M & Russo J 1990 Human chorionic gonadotropin and mammary cancer prevention. Journal of the National Cancer Institute 82 1286-1289.
47. Russo IH, Koszalka M & Russo J 1991 Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. British Journal of Cancer 64 481-484.
48. Russo J & Reina D 1985 Human chorionic gonadotropin hormone (hCG) as an inhibitor growth factor on MCF-7 cells. Proceedings of the American Association of Cancer Research 26 108a.
49. Russo J & Russo IH 1978 DNA-labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis. Journal of the National Cancer Institute 61 1451-1459.
50. Russo J & Russo IH 1980a Susceptibility of the mammary gland to carcinogenesis II. Pregnancy interruption as a risk factor in tumor incidence. American Journal of Pathology 100 497-511.
51. Russo J & Russo IH 1980b Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Research 40 2677-2687.
52. Russo J & Russo IH 1982 Is differentiation the answer in breast cancer pevention? International Research Communications (IRCS) 10 935-945.
53. Russo J & Russo IH 1987a Biological and molecular bases of mammary carcinogenesis. Laboratory Investigation 57 112-137.
54. Russo J & Russo IH 1987b Development of the human mammary gland. In The Mammary Gland Development, Regulation, and Function, pp 67-93. Eds MC Neville & CW Daniel. New York: Plenum,
55. Russo J & Russo IH 1993 Developmental pattern of the human breast and susceptibility to carcinogenesis. European Journal of Cancer Prevention 2 85-100.
56. Russo J & Russo IH 1994 Toward a physiological approach to breast cancer prevention. Cancer Epidemiology, Biomarkers and Prevention 3 353-364.
57. Russo J & Russo IH 1995 Hormonally induced differentiation: A novel approach to breast cancer prevention. Journal of Cellular Biochemistry 22 58-64.
58. Russo J & Russo IH 1996 Oestrogens and cell proliferation in the human breast. Journal of Cardiovascular Pharmacology 28 (Suppl) S19-S23.
59. Russo J, Russo IH, Ireland M & Saby J 1977a Increased resistance of multiparous rat mammary gland to neoplastic transformation by 7,12-DMBA. Proceedings of the American Association for Cancer Research 18 140.
60. Russo J, Saby J, Isenberg W & Russo IH 1977b Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz(a)anthracene. Journal of the National Cancer Institute 59 435-445.
61. Russo J, Wilgus G & Russo IH 1979 Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. American Journal of Pathology 96 721-734.
62. Russo J, Tay LK & Russo IH 1982a Differentiation of the mammary gland and susceptibility to carcinogenesis: A Review. Breast Cancer Research and Treatment 2 5-73.
63. Russo J, Miller J & Russo IH 1982b Hormonal treatment prevents DMBA induced rat mammary carcinoma. Proceedings of the American Association of Cancer Research 23 348a.
64. Russo J, Reina D, Frederick J & Russo IH 1988 Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Research 48 2837-2857.
65. Russo J, Mills MJ, Moussalli MJ & Russo IH 1989a Influence of breast development and growth properties in vitro. In Vitro Cellular and Developmental Biology 25 643-649.
66. Russo J, Russo IH, van Zwieten MJ, Rogers AE & Gusterson B 1989b Classification of neoplastic and non-neoplastic lesions of the rat mammary gland. In Integument and Mammary Glands of Laboratory Animals, pp 275-304. Eds TC Jones, U Mohr & RD Hunt. Berlin: Springer Verlag.
67. Russo J, Gusterson B A, Rogers AE, Russo IH, Wellings SR & Van Zwieten MJ 1990 Comparative study of human and rat mammary tumorigenesis. Laboratory Investigation 62 1-32.
68. Russo J, Rivera R & Russo IH 1992 Influence of age and parity on the development of the human breast. Breast Cancer Research and Treatment 23 211-218.
69. Russo J, Calaf G, Sohi N, Tahin Q, Zhang PL, Alvarado ME, Estrada S & Russo IH 1993a Critical steps in breast carcinogenesis. New York Academy of Sciences 698 1-20.
70. Russo J, Calaf G & Russo IH 1993b A critical approach to the malignant transformation of human breast epithelial cells. Critical Reviews in Oncogenesis 4 403-417.
71. Russo J, Romero AL & Russo IH 1994 Architectural pattern of the normal and cancerous breast under the influence of parity. Journal of Cancer Epidemiology, Biomarkers and Prevention 3 219-224.
72. Soule HD, Maloney TM, Wolman SR, Peterson, ND, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF & Brooks SC 1990 Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Research 50 6075-6086.
73. Tait LR, Soule HD & Russo J 1990 Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Research 50 6087-6094.
74. Tay LK & Russo J 1981a 7,12-Dimethylbenz(a)anthracene (DMBA) induced DNA binding and repair synthesis in susceptible and non-susceptible mammary epithelial cells in culture. Journal of the National Cancer Institute 67 155-161.
75. Tay LK & Russo J 1981b Formation and removal of 7,12-dimethylbenz(a)anthracene nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis 2 1327-1333.
76. Tay LK & Russo J 1985 Effect of human chorionic gonadotropin on 7,12-dimethylbenz(a)anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chemico-Biological Interactions 55 13-21.
77. Thompson HJ & Ronan A 1987 Effect of L-α- difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 57 2003-2009.
78. Trichopoulos D, Li FP & Hunter DJ 1996 What causes cancer? Scientific American 275 80-87.
79. Walker KJ, Bouzubar N, Robertson J, Ellis IO, Elston CW, Blamey RW, Wilson DW, Griffiths K & Nicholson RI 1988 Immunochemical localization of estrogen receptor in human breast tissue. Cancer Research 48 6517-6522.
80. Walker KJ, McClelland RA, Candish W, Blamey RW & Nicholson RI 1992 Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. European Journal of Cancer 28 34-37.
81. Wellings SR 1980 Development of human breast cancer. Advances in Cancer Research 31 287-299.
82. Wellings SR, Jensen HM & Marcum RG 1975 An atlas of subgross pathology of 16 human breasts with special reference to possible precancerous lesions. Journal of the National Cancer Institute 55 231-275.
83. Welsch CW 1985 Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Research 45 3415-3443.
84. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA & Potten CS 1991 Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. International Journal of Cancer 48 206-210.